28 June 2022
Title
Aetiology, diagnosis and management of testicular cancer and other benign and malignant scrotal conditions.
Date
Wednesday 27 July 2022
Time
7.00-8.15pm
Where
Online via Zoom
Overview
In this session, urological surgeon and uro-oncologist Dr Pras Sivam will discuss the presentation and management of benign and malignant conditions of the testes and scrotum. The diagnosis and management of testicular cancer will be explained in this interactive session. Case studies will be used for context.
As part of the multidisciplinary approach to patients’ treatment plans, exercise physiologist Molly Lowther will outline the benefits of incorporating a tailored exercise program for patients with cancer.
Topic and Speakers
Testicular cancer and benign and malignant scrotal conditions, Dr Pras Sivam, Urological Surgeon and Uro-Oncologist.
Exercise physiology and cancer, Ms Molly Lowther, Exercise Physiologist.
Moderator, Dr Jane Crowe, General Practitioner.
Program
7.00-8.00pm presentations
8.00-8.15pm Q&A
Learning Outcomes
By the end of this activity, participants will be able to:
- Better diagnose and manage patients presenting with scrotal problems.
- Identify the red flags for testicular cancer in patients presenting with pain or a mass.
- Explain the benefits of a tailored exercise program for patients with cancer.
RACGP
Two CPD activity points
Registration
Register online for this virtual event and provide the information below:
- First name and last name
- Practice name, suburb and postcode
- Email address (to which your individual registration confirmation and Zoom link will be sent)
- RACGP number
- Occupation
You will receive email confirmation and a link to join the Zoom meeting.
Please check your Junk or Spam if you don’t receive it in your Inbox.
Enquiries
Grace Linehan
Medical Liaison Officer
M: 0400 976 196
Related stories
News, Articles
Transperineal Prostate Biopsy under Local Anaesthetic
View results of pilot study to determine safety and tolerability of TPBx under LA.
Jun 20
News, Articles
Urological Biorepository (Biobank)
More than 35,000 samples preserved for downstream research into prostate cancer.
Jun 20
News, Articles, Research
World first medical device implantation to restore erectile function - Media Release
A world first implantation of a high-tech, battery powered device to restore erectile function, has taken place at RMH.
Dec 11
With your support, we can continue our fight
Help us continue our groundbreaking work in giving Australian men with prostate cancer longer, happier lives, and research to find a cure.
Donate now